Advertisement

Loading...

Stem Cell Authority, Ltd.

SCALPNK
Healthcare
Medical - Care Facilities
$0.00
$0.00(0.00%)
U.S. Market is Open • 10:07

Stem Cell Authority, Ltd. (SCAL) Stock Overview

Explore Stem Cell Authority, Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap17.4K
P/E Ratio-45.87
EPS (TTM)$0.01
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

SCAL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Stem Cell Authority, Ltd. (SCAL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.99, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -45.87 and a market capitalization of 17.4K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
0.00%
1-Month Change
100.000%
3-Month Change
100.000%
6-Month Change
0.00%
Year-to-Date (YTD) Change
100.000%
1-Year Change
N/A
3-Year Change
-96.67%
5-Year Change
-99.33%
All-Time (Max) Change
-99.00%

Contact Information

330-835-0200
123 South Miller Road, Fairlawn, OH, 44333

Company Facts

IPO DateMar 17, 2005
CountryUS
Actively Trading

Frequently Asked Questions